Money Talk Sundayz

Is it time to buy JAGX? The company has an average price target of $14. Over the last month it has fallen 43.39% so it seems investors are less bullish about the stock than before. That’s all fine and dandy but for people first time hearing about this stock, can they make a quick buck with it? Let’s find out.

Welcome to Money Talk Sundayz. Click that thumbs up button below to check in. Share and subscribe if JAGX is something you’re interested in. Let’s rap Jaguar Health.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders.

The stock closed yesterday at 2.05. Today it opened at 2.06 and is currently at 2.10. In the last 52 weeks JAGX was a low as 0.56 and as high as 13.41 with an average 100 day trading volume of 2,607,031.

Personally, I just came across this stock the other day while looking up something else. I figured I’d talk about it with you guys, bros nation, since at the heart, the core of this podcast, it’s about how two brothers play the market.

I’m intrigued about this stock mostly because of the low buy-in opportunity. After infusing thousands of my personal dollars into these market ventures, I’m shifting towards no longer having to use my dollars but rather the profits from swing and options trades to continue building my portfolio. Like they say, make your money make money.

Now, JAGX is set to release their earnings on 11/11/2021. During their last earnings release the company posted EPS of $-1.14.

Now as far as the charts are concerned, JAGX is down 27.42% over the last 30 days losing 0.7947 cents a share. Over the last 3 months, it is down 57.10% losing 2.77 per share. But again over the last year it is up 107.21% however it is trending downwards.

Based upon the chart patterns I’m seeing that it has more falling to do before we see another resurgence in price. By how much more I can’t say but I would ballpark it falling back down to 1.50. What I would do at this moment would be to add it to my watchlist and set alerts for a rapid rise as well as an alert for when it hits my expected floor. Once it bottoms out I’ll then hop in.

My recommendation is swinging this sucker the long way.

It is high time that something is done about Goldman Sachs. The amount of corruption breeding from this giant is undeniable and yet we the people continue to turn a blind eye. The pattern of abuses by this bank and I use the term loosely is so profound but because of the cash flow and the number of hands in the pot they continue to be slapped with fines and lip service but no real change. 

In the latest chapter for Goldman Sachs, alums of the fine institution, Carlos Watson and Samir Rao, founded Ozy Media and proceeded to acquire funding from good ole Goldman. Everything was going fine until investors is Ozy started sniffing around and asking questions. Apparently someone didn’t like what they found and now Ozy is being sued in California federal court alleging it knowingly failed to disclose among other things that one of its founders impersonated a YouTube executive and misrepresented Ozy's programming viewership.

But this isn’t the first time Goldman has been supposedly duped by Ozy. In the last month, insiders say David Solomon’s bank spent nearly $300,000 on a new advertising partnership with Ozy, which last week went up in flames over a series of scandals that also included lying about getting cash from Sharon and Ozzy Osbourne.

Six years ago, Goldman spent more than $20,000 to place ads in Ozy’s newsletter over the course of a month in the hopes of boosting the number of subscribers to the Goldman Sachs newsletter “Briefings,” the sources said.

The marketing team, the real workers, were skeptical about the promises made by Ozy and company but Goldman execs forced the team to move forward with Ozy. Ultimately that investment netted them maybe a dozen subscribers when Ozy claimed an influx of new subs would be had from their hundreds of thousands of subscribers. 

But wait, there’s more!

In late October, the United States Department of Justice announced a major settlement with the global investment bank Goldman Sachs for its involvement in the 1MDB scandal, an international bribery scheme in which high-level Malaysian officials embezzled an estimated $4.5 billion from a fund designed to finance infrastructure and other economic development projects. Between 2012 and 2013, Goldman Sachs helped raise $6.5 billion for 1MDB in three bond sales, and at least two Goldman bankers aided Jho Low, an advisor to the fund, in embezzling much of the capital. As part of the settlement with DOJ, Goldman agreed to pay over $2.9 billion to authorities in the US, Hong Kong, UK, and Singapore. Of the nearly $3 billion in fines, approximately $1.85 billion will go to the United States, over $600 million to Malaysia (on top of a $3.9 billion settlement the Malaysian branch of Goldman reached with the country in July), and $440 million to financial regulators in other nations.

Goldman Sachs is ripe for corruption and greed. Since 2000 the bank has been fined a staggering $16,381,931,839. There are 64 recorded violations by the bank on the violation tracker website. 

This bank can be fined this much but the US is on the verge of default if the debt ceiling isn’t raised. What’s really going on? I’ll let you be the judge. 

Vaxart begins phase 2 clinical trials of Covid-19 vaccine tablet. 

Brief Summary:

Part 1: An open label, dose and age escalation phase to evaluate the safety and immunogenicity of VXA-CoV2-1.1-S with a repeat-dose vaccination schedule in healthy adults aged 18 - 75 years old that are either vaccine naive or have received prior vaccination with an mRNA (messenger ribonucleic acid) vaccine for the prevention of COVID-19.

Part 2: This phase will assess the efficacy of prophylactic VXA-CoV2-1.1-S against confirmed COVID-19 occurring from 7 days after second dose with a repeat-dose vaccination schedule in healthy adults compared to placebo. Safety and immunogenicity of VXA-CoV2-1.1-S will also be evaluated in this phase.

https://clinicaltrials.gov/ct2/show/NCT05067933?recrs=abdfm&cond=COVID-19&phase=1&draw=11&rank=95

Detailed Description:

Part 1: This is an open-label, dose-ranging phase of the study to determine the safety and immunogenicity of an orally administered adenoviral-vector based vaccine (VXA-COV2-1.1-S) expressing a SARS-CoV-2 antigen and dsRNA adjuvant. Post screening activities, healthy adult volunteers, either naïve or prior vaccinated with an mRNA COVID-19 vaccine, aged 18 - 55 yrs old, and then 56 - 75 yrs old, will be enrolled into the study in 8 subgroups. Participants will receive either a low or a high dose of an oral tableted vaccine at Days 1 and Day 29. The total study period will last ~ 2 months during the active phase, with a total 12 month safety follow-up period post last vaccination. Safety, reactogenicity and immunogenicity assessments will be performed at set times during the study active and follow-up periods. Subjects will be monitored for symptoms of COVID-19 throughout the duration of the study follow-up period. An independent data monitoring committee (IDMC) will provide safety oversight through the duration of the trial. Safety and immunogenicity data will inform on the dose selection for Part 2.

Part 2: This will be a placebo-controlled phase with the vaccine dose level selected from Part 1. Subjects will receive two doses of vaccine or placebo at Days 1 and 29. Subjects will be followed as in Part 1 for safety and immunogenicity. They will also be followed for 6 months for efficacy.

Bumpy September is out of the way and a race to the moon is on for the rest of the year folks. The race does come with its share of obstacles i.e., the debt ceiling issue that hasn’t been resolved as of yet. But crypto is still chugging along despite market volatility. BTC and ETH continue to be the mainstays in the field however a need for faster network speeds and lower transaction fees is pushing investors to alternative choices. For more on this you’re going to have to stick around.

Welcome to Money Talk Sundayz. Hit the like button on your way in. Let’s talk cryptocurrency.

Big dog Ethereum appears to be losing steam falling behind ETH killers Solana, Cardano and Polygon. Over the past year the value of Ethereum increased by 830% making it the second highest crypto by market value. During the month of September, the coin’s value dropped 16%. This decline was fueled not only by September uncertainty and hesitancy but also by the slow network speeds and high transaction fees plaguing the asset.

It is here where the altcoins shine. Solana has seen almost a 4800% growth since September of last year. Solana boasts cheaper fees and faster usage than Ethereum. But that’s not all. Solana has found a driver in the NFT and DeFi market. Solana is processing 50,000 transactions per second at only $0.00025 per transaction. Ethereum has not come up with a way to compete with that. Ethereum’s transaction speed is limited to 13 transactions per second with much higher fees than Solana.

Investors are catching on and while not completely leaving ETH outright, they are diversifying and giving a bigger piece of the crypto pie to alternative blockchains.

For example, Grayscale, a crypto asset manager, has added Solana and Uniswap to one of its funds per the Market Insider. The company said it had added the solana network's sol token and uniswaps' uni to its Digital Large Cap Fund, which has $494.6 million assets under management, according to its website. The weightings were adjusted so that bitcoin would have the largest weight followed by ether, ada, sol and then uni based on "quarterly reviews", Grayscale said.

If that wasn’t all, Solana-based NFT SolMonkey sold for $2 million. SolMonkey was the latest Solana-based non-fungible token to be sold at a very expensive price. Earlier this month, The Block Crypto reported that the SolMonkey was only sitting at more than $1 million value three weeks ago. Some people doubt Ethereum blockchain's dominance in the market since many NFTs are struggling to keep up there. However, the #1355 Solana Monkey, which depicts a skeletal monkey donning a colorful crown, has been bought for $2 million. In the collection, it was said to be the most unique NFT.

In more NFT/Solana news Genopets a Play-to-Earn NFT Game has announced its decision to build on the Solana ecosystem. According to the announcement, Genopets revealed that more than a million people actively played a Play-to-Earn blockchain game daily.

Also, the blockchain gaming platform revealed that its decision to build on Solana was due to its scalability, top-notch security, fast transactions, cheap costs, among others.

“[…] Solana is scalable and cost-efficient, so you don’t have to worry about growth on fragmented Layer 2 systems or sharded chains,” Genopets noted.

While I’m still on the fence when it comes to the lasting power of NFT’s this is affirmation that Solana itself is a great investment.

Another Solana convert is Bancambios. The long-awaited Bancambios DeFi initiative has finally begun. The token (ticker: BX) will be created over the Solana blockchain, and the foremost invitation to join will be sent to the Solana and DeFi communities. Bancambios is on course to meet its blueprint release deadline (Q4 2021 – Q2 2022).

Bros Nation, I know, I know. I said we were going to be off this week for my birthday this weekend but news came across my desk about one of my favorite stocks, VXRT. This is good news/bad news depending on how you look at it but news nonetheless. The ongoing lawsuit with VXRT continues despite a much anticipated Sept 30 resolution date. The judge overseeing the case deals a blow to VXRT and investors respond in kind. For more on this stay tuned.   

Welcome to the Money Talk Sundayz podcast. I’m your Investment Bro Stevie Bee. Do the channel a solid and hit that like button. If you’re not already subscribed you can do so now or at the end of the video. Finally, if you have friends that are invested in Vaxart or VXRT share this video. The latest VXRT news leaves me with mixed feelings but still bullish.   

On September 30, 2021 Judge Vince Chhabria called Vaxart out on their dismissal claims accusing the biotech company and controlling owner, hedge fund Armistice Capital LLC of burying investors in an “avalanche of bs”. The judge did not outright rule that the defense were guilty of what they were being accused of but did go so far as to say that the allegations made against them were “plausible”.

Quick background as to the nature of the lawsuit. VXRT and Armistice are being sued for multiple materially misleading statements in June 2020 that claimed it was partnering with Attwill Medical Solutions Sterilflow LP to produce "a billion or more" COVID-19 vaccine doses per year, even though Attwill wasn't certified to produce the vaccines. Vaxart also claimed a day later that its Covid-19 vaccine had been "selected for the U.S. Government's Operation Warp Speed.” That wasn’t the case at all.

During a hearing held via Zoom, Judge Chhabria said it appears that the investors have plausibly alleged that Vaxart Inc. and its majority stockholder and controlling owner, hedge fund Armistice Capital LLC, intended to artificially prop up the price of the penny stock. It also appears that the investors have plausibly alleged that the defendants intended to make a series of misleading statements in order to prop up the stock price, the judge said.

"Is that what happened? I don't know," the judge said. "But I think that that has been plausibly alleged."

In VXRT’s defense, Riccardo DeBari of Thompson Hine LLP, argued that the allegations hinge on a mere "10 words" at the beginning of a press release that are unactionable, forward-looking statements that were aspirational and that only “nitwits” would have been duped by the numerous press statements released by Vaxart.

The judge disagreed pointing to the statements made back in June 2020 as seemingly credible intel for sophisticated investors. The judge went further revealing that at the time of the press statements Vaxart only had roughly 25 – 30 people working at the company making it highly unlikely they would have the capacity to produce billions of vaccines annually.

"It's just absurd," the judge said, adding that "clearly" the company should have known that they didn't have the capability to produce that many vaccines.

Now the judge did not issue a ruling at the end of the hearing instead asking both sides to submit additional case law citations for him to review before doing so.

Now from what I’ve read on the hearing an order date is not set so we’re playing the waiting game just like in the case of Ripple and XRP. What is notable is that shares of VXRT dropped to as low as 7.06 as of this recording. The drop is further fueled by another Covid-19 vaccine tablet shines in late stage trials from Merck & Co. Merk is leading the race in developing an oral pill for the virus with studies showing that their candidate greatly reduces chances of hospitalization or death among patients at risk of severe illness. Merk is currently trading at 81.40.

China banned crypto again which sent the crypto market reeling but not for long. It’s not the first time that it happened and it won’t be the last. Don’t be fooled. You can only delay the inevitable but for so long before being overtaken by it. Crypto is the future of currency. Get in NOW!!!

Welcome to Money Talk Sundayz. I’m your Investment Bro, Stevie Bee. Hit that like share and subscribe button when you come in the door.

Lets talk Twitter!

Twitter announced that its 330m active users will soon be able to send bitcoin to each other instantly and for virtually zero cost – harnessing the Lightning network that’s been built on top of bitcoin’s primary layer and, many believe, will propel the cryptocurrency into the mainstream.

One bitcoin was worth $42,666 on the Bitstamp exchange at 16:00 EST Saturday, holding above its long-term moving averages and surpassing its value at the beginning of August.

The digital currency briefly dipped below $40,700 on Friday, when the so-called People's Bank of China – a Communist government-controlled central bank – declared that all cryptocurrency-related activities were “strictly prohibited” in the country. Beijing accused the cryptocurrency industry of “disrupting economic and financial order” and “endangering the safety of people's property”.

That clampdown triggered a 20% crash in bitcoin’s price, yet the latest, more draconian measure has moved the needle by less than 5%.

Bitcoin was almost completely unchanged on Saturday, having found strong support at its 200-day exponential moving average.

While everyone was freaking over the latest move by China, news coverage of the positive adoption by Twitter TWTR +0.8% was almost entirely restricted to financial outlets like Bloomberg and CNBC.

Twitter began integrating the Strike bitcoin Lightning wallet with its platform last week, enabling users to send and receive bitcoin as easily as tweeting out a thought.

Critics of bitcoin have long argued that the cryptocurrency can’t be scaled for mass adoption because of its high costs and slow processing times. Average transactions on bitcoin’s primary layer typically cost around $8 and take about 20 minutes to be validated, although fees and timeframes vary in-line with network demand.

Lightning solves this problem by processing transactions off-chain through a secondary layer that can, in theory, handle millions of payments a second (Visa, by comparison, processes about 1,700 payments a second).

Users interact with the Lightning network through purpose-built mobile wallets such as Strike and Muun. In El Salvador, which formally recognized bitcoin as legal tender this month, citizens are already making micro-payments for coffees and newspapers with their national digital wallet, Chivo.

Given the lack of media attention, it’s no surprise that the Lightning network remains small today: less than 3,000BTC is currently locked in the protocol. But its capacity has risen steadily this year and is likely to surge as Twitter completes its integration for all users over the coming weeks.

China is, undoubtedly, worried about bitcoin – but not because of money laundering, phishing scams or economic destabilization.

China is worried because bitcoin gives its citizens the freedom to teleport their wealth around the world instantly at the click of a button – side-stepping the short-sighted, arbitrary capital restrictions that Beijing is no doubt planning in response to the Evergrande debacle.

What does this mean for BTC, hiccups will come but the crypto is more than ready and capable to deal with all the hurdles that comes its way. Get you some if you haven’t done so already!

This is your investment bro Stevie Bee with Money Talk Sundayz. Again hit that like, share and subscribe button. We’re off this week. I’m celebrating my b-day so…. Yeah Libra Gang!

Happy trading folks!

So you want to know about SNDL. I’m not going to go into the back story of SNDL. If you’re asking about Sundial you already know what the company is about. Million dollar question is, do you invest or not. Simple answer, depends on how you’re investing. Let’s break it down.

Welcome to Money Talk Sundayz. Hit that like button on your way in the door. If you’re not already subscribed what re you waiting on? Let’s get his movement going. If you make it to the end of this episode please share. SNDL.

For the record I am not currently invested in SNDL but I was in the past. I swung it. Made some money when it broke a dollar and bounce out. That was several months ago. I haven’t jumped back in since BUT I have been keeping up with SNDL news for the most part in anticipation of another move. There hasn’t been any new recently that has motivated me to get back in but in the back of my head I do want to hop back in and I just might but only as a long swing trade.

Currently, the Canadian cannabis market is showing signs of saturation. That being said, SNDL is not looking as a market leader… yet. However the two pillar pivot is promising as it gives SNDL stable cashflow and a way to benefit from the saturation and legislative hurdles.

Sundial Growers' offerings center around adult cannabis use. They recently pivoted into what insiders call a ' two-pillar approach which is centered around the production of cannabis-related products and their investment arm Sunstream Bancorp.

Their production segment comprises inhalable products, such as pre-rolls, flowers, and vapes. Grasslands, Sundial Cannabis, Top Leaf, and Palmetto are the brands under which Sundial Growers offer their products.

Boasting a wide array of products in the cannabis space at multiple price points the company is still struggling to find consistency when it comes to profits. There is room for the company to focus its efforts on the more profitable sides of its business and the dried flower category has carried revenue for the company in the past accounting for more than 50% of revenue for the segment. The company is instead focusing on engaging its franchisees which is a positive. The company is also working on a Franchisee Advisory Council which will be tasked with flattening communications with franchisees so the company can dial into the growth dynamics the franchisees are seeing on the front line.

Sundial continues to invest heavily in streamlining the cultivation process and cost control. They also have an emphasis on vertical integration which jives well with their recent decision to Pivot into investment operations. Sundial seems focused on having positions all across the value stream end the Cannabis space which can be compelling or not depending on how you view the industry's prospects over the long term.

The challenge is the market saturation makes it difficult for the company to differentiate itself from its peers. The company hasn't really been able to find major success in this segment yet but as attrition thins out the competition in the Canadian market that may change. In the meantime, the company is focusing on increasing efficiency and improve its internal cost controls to protect its robust liquidity position which is prudent.

This is Stevie Bee for Money Talk Sundayz. If you haven’t done so already hit that like button. If you made it this far hit that subscribe and share button. I’m definitely open to you guys and hearing what you have to say so drop a comment or a dm. We’re going to do this. One love.

Welcome to Money Talks with your Investment Bro Stevie Bee. I just have one question to ask my viewers today… Are NFTs finally seeing the door? You know, that new fad that hopped on the scene in the last year called non-fungible tokens. From the jump I was extremely skeptical of its lasting power. In my opinion it was almost as ludicrous as paying any amount of money for an invisibly sculpture or for a banana taped to a canvas… but when you have money all bets are off I guess. Despite my skepticism there has been good money that has changed hands and I would be remiss to not secure a piece of that exchange. So I invested in YVR. I did a swing trade on YVR, made a couple hundred dollars and bailed out. That is the extent of my NFT experience.

But now signals are pointing to what many predicted. According to CointeleGraph, data shows that a majority of the lower-priced NFTs and lesser-known projects in the market do not accrue value and this means that the sector is rather illiquid. Using data from OpenSea, a recent report from Bloomberg found that 73.1% of NFT assets had only one transaction in the past 90 days.

While this may only be just a snapshot of the overall NFT market, the data itself raises eyebrows given that investors looking to buy NFTs on average pay well over $100 to mint a new NFT and cover the fees needed to transfer the asset.

In comments to Bloomberg, Gauthier Zuppinger, the COO of Nonfungible, said that “maybe 90% of collections minted today are totally useless and meaningless.”

Regarding 'successful' NFT investing, Zuppinger:

“Ninety-nine percent is about being in the right circle, having the right information at the right time. In the NFT space, you live with this constant frustration that you have missed a chance to make $1 billion.”

The number of sales being made on marketplaces has cooled off from its August highs as well. The number of daily sales across all NFT marketplaces has declined from a high of 138,109 on Aug. 30 to 42,372 on Sept. 21.

A similar chart pattern is seen across multiple NFT marketplace metrics including the dollar value of sales completed, active market wallets, primary market sales, secondary market sales, unique buyers and unique sellers.

In short, the NFT market is dying out. People are catching on and realizing it for the farce that it is. Yet another pump and dump in something that ultimately is worthless and in a lot of cases turns out to be fungible after all.

Fungible is defined as “being of such nature or kind as to be freely exchangeable or replaceable, in whole or in part, for another of like nature or kind.” Many of these NFTs are exchangeable and/or replaceable in whole or in part.

Thou hast been duped if thou hast partaken in the acquisition of most NFTs. To avoid this, I invested in the platform on which the exchanges occur. As the hype rose, so did the share price hence my swing trade. I hopped out just prior to the cool down and I must say it was a nice little quick run. Like SNDL for example, I jumped in when it was pennies on the dollar, rode it over that dollar mark and secured my profit and sent it packing. Since then, the stock has struggled to gain traction above 72 cents.

In summary, for the activity that is still occurring in the market, “the most actively traded 3% of collections accounted for 97% of all dollar volume,” according to Bloomberg, suggesting that the NFT market is behaving a lot like the wider altcoin market where a small percentage of the tokens receive a majority of the trading volume.

But this is just my take on NFTs. If you have a different experience with them share it with me. Im far from the brightest in the bunch and common sense is not all that common anymore so… help me see what I’m missing. It can’t really be that much being missed here. What do you think?

The market clearance sell continues today after last week’s quad witching. What that means for folks afflicted with FOMO (Fear of Missing Out), you once again have an opportunity to jump in at a good entry point stocks and crypto. So what are a couple promising plays? Stay tuned to find out.

Subscribe: https://anchor.fm/moneytalksundayz/subscribe

Let’s start off with the crypto market. The value of the world's cryptocurrencies plunged to a low of less than $1.9 trillion by 8:45 a.m. EDT on Monday, nearly 11% less than 24 hours prior and reflecting a loss of more than $250 billion, according to crypto-data website CoinMarketCap. Shout out to China for keeping the market on its toes and speculating. With the virus still dominating investor concerns, markets were jolted by news of Evergrande, a major Chinese real estate company that's teetering on the brink of default. China's potentially slowing economy, and Beijing's aggressive actions against key business sectors, have converged with worries about the global economy. Meanwhile, a fight is brewing in Washington over raising the U.S. debt limit per Yahoo! Finance.

Today, this somewhat obscure, overseas risk suddenly shook up financial markets from Asia to Europe and the U.S., where all three major benchmark stock indexes, the S&P 500 SPX, -1.70%, Dow industrials DJIA, -1.78% and Nasdaq Composite COMP, -2.19% appeared to be headed for the worst one-day drop in more than two months. Though it is certainly not the only reason U.S. stocks slid, Evergrande was a factor behind investors’ risk-off mood.

On one level, Evergrande—which reportedly faces at least $83.5 million in interest payments due on Thursday, with a 30-day grace period — is raising concerns about a liquidity crisis among all Chinese and Hong Kong property companies, as markets quickly turn off access to dollar funding. In a more macro way, the firm’s woes are bringing to the fore China’s wide-scale regulatory crackdown across most of its businesses, starting with technology giant Alibaba Group Holding Ltd. 9988, -2.19%, which is rattling confidence in the world’s second-largest economy.

You can’t really go wrong with BTC and ETH. The value of these coins right now are about as good as its going to get. Expecting the coins’ value to drop in half is wishful thinking so now is as good an entry point as any.

In fact, since hitting a September high of almost $53,000 after El Salvador officially introduced bitcoin as legal tender, the crypto unit is off by more than $8,000.

Aside from the obvious BTC and ETH, Solana and ATOM are really good choices to establish your position prior to the next run up. I’m a fervent believer in XRP and currently with it falling under a dollar, it’s another great option to get more bang for your buck. In the past I used to tout Dogecoin as the coin to buy BUTTTTT while I still believe it has its merits, I’m looking for plays that will pop off quicker, sooner than Doge.

In regards to stocks, now is a great time to jump on VXRT if you haven’t done so already. VXRT has seen its SMA50 which is now 1.12%. In looking the SMA 200 we see that the stock has seen a 11.17%. It’s also a good time to get in on OKE, ARKK, and SPG. With the market in the toilet people are selling off to hedge their losses which creates a wonderful buying opportunity for those with resources available to snatch up the sales. I for one had to go ahead and scoop up a few things while also running a couple option plays on Apple, NIO, and VXRT.

The market clearance sell continues today after last week’s quad witching. What that means for folks afflicted with FOMO (Fear of Missing Out), you once again have an opportunity to jump in at a good entry point stocks and crypto. So what are a couple promising plays? Stay tuned to find out.

Subscribe: https://anchor.fm/moneytalksundayz/subscribe

Let’s start off with the crypto market. The value of the world's cryptocurrencies plunged to a low of less than $1.9 trillion by 8:45 a.m. EDT on Monday, nearly 11% less than 24 hours prior and reflecting a loss of more than $250 billion, according to crypto-data website CoinMarketCap. Shout out to China for keeping the market on its toes and speculating. With the virus still dominating investor concerns, markets were jolted by news of Evergrande, a major Chinese real estate company that's teetering on the brink of default. China's potentially slowing economy, and Beijing's aggressive actions against key business sectors, have converged with worries about the global economy. Meanwhile, a fight is brewing in Washington over raising the U.S. debt limit per Yahoo! Finance.

Today, this somewhat obscure, overseas risk suddenly shook up financial markets from Asia to Europe and the U.S., where all three major benchmark stock indexes, the S&P 500 SPX, -1.70%, Dow industrials DJIA, -1.78% and Nasdaq Composite COMP, -2.19% appeared to be headed for the worst one-day drop in more than two months. Though it is certainly not the only reason U.S. stocks slid, Evergrande was a factor behind investors’ risk-off mood.

On one level, Evergrande—which reportedly faces at least $83.5 million in interest payments due on Thursday, with a 30-day grace period — is raising concerns about a liquidity crisis among all Chinese and Hong Kong property companies, as markets quickly turn off access to dollar funding. In a more macro way, the firm’s woes are bringing to the fore China’s wide-scale regulatory crackdown across most of its businesses, starting with technology giant Alibaba Group Holding Ltd. 9988, -2.19%, which is rattling confidence in the world’s second-largest economy.

You can’t really go wrong with BTC and ETH. The value of these coins right now are about as good as its going to get. Expecting the coins’ value to drop in half is wishful thinking so now is as good an entry point as any.

In fact, since hitting a September high of almost $53,000 after El Salvador officially introduced bitcoin as legal tender, the crypto unit is off by more than $8,000.

Aside from the obvious BTC and ETH, Solana and ATOM are really good choices to establish your position prior to the next run up. I’m a fervent believer in XRP and currently with it falling under a dollar, it’s another great option to get more bang for your buck. In the past I used to tout Dogecoin as the coin to buy BUTTTTT while I still believe it has its merits, I’m looking for plays that will pop off quicker, sooner than Doge.

In regards to stocks, now is a great time to jump on VXRT if you haven’t done so already. VXRT has seen its SMA50 which is now 1.12%. In looking the SMA 200 we see that the stock has seen a 11.17%. It’s also a good time to get in on OKE, ARKK, and SPG. With the market in the toilet people are selling off to hedge their losses which creates a wonderful buying opportunity for those with resources available to snatch up the sales. I for one had to go ahead and scoop up a few things while also running a couple option plays on Apple, NIO, and VXRT.